Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lantern

Explore full profile

Formerly known as Employer Direct Healthcare | Specialty care platform for employer health plans.

Dallas, United StatesFounded 2010Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2023
Headcount 500–1k Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Lantern and the history behind them.

About Lantern

Lantern operates as a specialty care platform designed to connect members of self-funded employer health plans with high-quality, cost-effective medical care for complex needs. The company, headquartered in Dallas, Texas, targets the highest-cost areas of healthcare spend for employers, which include surgery, cancer care, and infusion therapies. Lantern's business model is centered on providing a supplemental health benefit to large employers, public sector entities, and labor unions. It curates a proprietary "Network of Excellence" by directly contracting with top-performing specialists and facilities, including ambulatory surgery centers and hospitals, across the United States. This model aims to deliver significant cost savings to employers—reportedly over 55% lower rates than average health plans—while improving clinical outcomes for patients. The company was founded in 2010, and was previously known as Employer Direct Healthcare and operated with SurgeryPlus as its core product. In September 2024, the company rebranded to Lantern to reflect its expansion beyond surgery into a multi-faceted specialty care platform. John Zutter, who has a background in investment banking and private equity with J.P. Morgan and Dundon Capital Partners, joined as CEO in 2016. Under his leadership, Lantern grew from approximately 100,000 members to over 6 million, serving more than 1,000 employers. The company's growth was supported by several funding rounds, including a $30 million investment in March 2026 led by Morgan Health, a JPMorgan Chase business unit, and Echo Health Ventures. Lantern's platform functions as an evolution of the traditional Centers of Excellence (COE) model by emphasizing local, accessible care to drive higher utilization. The company reports that providing local access can increase utilization by five to eight times compared to models requiring travel. For members, Lantern provides a dedicated care team of care advocates and nurses who offer personalized support throughout their entire treatment journey, from diagnosis and scheduling to post-treatment follow-up. This service helps members navigate the complex healthcare system, access second opinions, and get scheduled for care faster than the national average. The platform's key services cover planned surgeries, comprehensive cancer care, and both in-home and ambulatory infusion therapies.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2010
Headquarters
Dallas, United States
Employees
720
Open positions
None listed
Dealroom signal
91.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Verified Unicorns and $1B Exits, Hard Tech
Client focus
b2b, b2c

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VC✓Equity / VC Mar 2026 $30M — Echo Health Ventures · Morgan Health ↗
SECONDARY✓Other financing Dec 2023 $92M $1B Insight Partners ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Lantern website traffic

Latest recorded traffic for Lantern is 31K monthly website visits, up 5640.7% over the last three months. Lantern's team grew 18.6% over the past year.

Latest monthly visits31K 3-month web change+5640.7% 1-year team growth+18.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • TEXO Ventures

Series B and later5 investors entered at this stage

  • Dundon capital partners
  • Serent Capital
  • Insight Partners
  • Morgan Health
  • Echo Health Ventures

Other known investors4 additional known investors

  • Risk Strategies
  • Central Texas Angel Network
  • Randall Crowder
  • Wild Basin Investments
Team profiled 27 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 14 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States97.1%
🇨🇦 Canada2.1%
🇮🇳 India0.4%
🇩🇿 Algeria0.2%
🇬🇧 United Kingdom0.2%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lantern on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lantern’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.